focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
There are no guarantees Sierra will even be able to partner or progress SRA737 even with the reduced milestones. There are now thousands of clinical trials backlogged paused and halted around the world because of covid it’s potentially going to be a very long wait until any potential trial is announced and starts with the subsequent £400k being triggered on the dosing of the first patient.
Pfizer/BioNTech vaccine appears effective against mutation in new coronavirus variants
https://www.reuters.com/article/health-coronavirus-pfizer-vaccine/pfizer-biontech-vaccine-appears-effective-against-mutation-in-new-coronavirus-variants-study-idUSL1N2JI2LZ
7th Jan is 9 months
Sareum is eligible for c.£0.90m due on certain milestones being achieved within nine months of signing and receipt of programme data by the Licensee, The Licensee confirmed receipt of the programme data on 7 April 2020.
Let’s hope it’s positive news and not returned, delayed or extended without the much needed milestone GLA
Still here nothing’s changed not into conspiracy theories no shortcuts as stated by the bod so July onwards for the covid lab results.
Not long for an update on FLT3 let’s see if it’s a precursor to raise and that’s not a deramp no point applying for a CTA if you have no way of funding a P1 and before Thoth starts with grants and his theories a raise should be seen as a positive not a negative if the data supports it, time for the bod to get proactive if our TYK2’s are really good enough otherwise more dither and delay and the gravy train continues…….
As always DYOR and GLA